tiprankstipranks
Trending News
More News >
Crispr Therapeutics (CRSP)
:CRSP
US Market
Advertisement

Crispr Therapeutics AG (CRSP) Ownership - Who Owns Crispr Therapeutics AG?

Compare
9,780 Followers

Crispr Therapeutics AG (CRSP) Ownership Overview

1.69%14.61%0.21%20.97%62.52%
0.21% Other Institutional Investors
20.97% ETFs
62.52% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail, and individual investors. Approximately 35.79% of the company’s stock is owned by Institutional Investors, 1.69% is owned by Insiders, and 62.52% is owned by Public Companies and Individual Investors.
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail, and individual investors. Approximately 14.82% of the company’s stock is owned by Institutional Investors, 1.69% is owned by Insiders, and 20.97% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 17, 2025
xxxxxxxxxxxxx
$51499918
Feb 28, 2025
xxxxxxxxxxxxx
$313880

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,165,400Institution11.77%573,531,868
9,390,961Institution10.87%529,838,020
4,056,113Institution4.70%228,845,895
2,553,293Institution2.96%144,056,791
1,647,885Institution1.91%92,973,672
1,617,368Institution1.87%91,251,903
1,589,758Institution1.84%89,694,146
1,492,600Institution1.73%84,212,492
1,328,770Institution1.54%74,969,203
1,048,951Insider1.21%59,181,815

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,553,293Institution2.96%144,056,791
1,647,885Institution1.91%92,973,672
1,492,600Institution1.73%84,212,492
1,328,770Institution1.54%74,969,203
958,186Institution1.11%54,060,854
937,284Institution1.09%52,881,563
845,610Institution0.98%47,709,316
689,399Institution0.80%38,895,892
351,358Institution0.41%19,823,618
345,748Institution0.40%19,507,102

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,045,306Institution8.16%397,496,165
2,101,786Institution2.43%118,582,766
2,054,475Institution2.38%115,913,480
1,428,058Institution1.65%81,113,694
1,342,340Institution1.55%48,713,519
715,314Institution0.83%40,358,016
514,187Institution0.60%29,010,431
405,953Institution0.47%23,058,130
343,822Institution0.40%19,529,090
256,064Institution0.30%9,292,563

FAQ

Who Owns Crispr Therapeutics (CRSP)?
According to the latest TipRanks data, approximately 0.21% of the company's stock is held by institutional investors, 1.69% is held by insiders, and 62.52% is held by retail investors.
    What percentage of Crispr Therapeutics (CRSP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.21% of Crispr Therapeutics (CRSP) stock is held by institutional investors.
      What percentage of Crispr Therapeutics (CRSP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 62.52% of Crispr Therapeutics (CRSP) stock is held by retail investors.
        Who owns the most shares of Crispr Therapeutics (CRSP)?
        Cathie Wood owns the most shares of Crispr Therapeutics (CRSP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis